Nanocarriers for Ocular Therapeutics : Development and Evaluation of Nanoplex Delivery System (2010. 164 S. 220 mm)

個数:

Nanocarriers for Ocular Therapeutics : Development and Evaluation of Nanoplex Delivery System (2010. 164 S. 220 mm)

  • オンデマンド(OD/POD)版です。キャンセルは承れません。
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版
  • 商品コード 9783843358828

Description


(Text)
Ocular drug delivery is one of the most interesting and challenging endeavours because the anatomy and physiology of the eye render this organ exquisitely impervious to foreign substances including drugs. Conventional ocular formulations are no longer adequate and currently, nanocarriers for delivering drugs to the eye is emerging as an important area of drug delivery research. This book, therefore, focuses on PLGA-chitosan Nanoplexes as novel nanocarriers for ocular therapeutics. The development of Nanoplex carriers, their uptake mechanism and interaction with ocular surface, and their use for the treatment of ocular keratitis are discussed. The results should help shed some light on the use of these novel nanocarriers for ocular therapeutics, and should be especially useful to researchers or scientists working in the field of nanotechnology and drug delivery, pharmaceutical companies dealing with ocular therapeutics, and upto some extent to professionals associated with health care.
(Author portrait)
Gaurav K Jain, PhD in Pharmaceutics has studied Pharmaceutical Sciences at Hamdard University. He is presently working as an Assistant Professor in the Dept. of Pharmaceutics, Hamdard University, India. His research areas include development of nanocarriers for drug delivery and his research has been published in peer-reviewed journals.

最近チェックした商品